Zealand Pharma A/S (ZLDPF) Stock Chart & Stock Price History $66.00 +5.00 (+8.20%) As of 09:38 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Zealand Pharma A/S Stock Price Performance The Zealand Pharma A/S (ZLDPF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 49.51%, with a year-to-date return of -35.52%. In the past month, the stock has increased 8.10%, reflecting recent market activity. As of the latest close, Zealand Pharma A/S traded at $61.00 with a market cap of $4.33 billion and volume of 20 shares. Five years ago, the stock traded at $37.40, representing a 76.47% increase over that period. At the time, it had a market cap of $1.34 billion and a volume of 0 shares. Receive ZLDPF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Zealand Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+8.20%1 Month Performance+8.10%3 Month Performance+5.84%Year-To-Date Performance-35.52%1 Year Performance-49.51%5 Year PerformanceN/A ZLDPF Stock Chart for Monday, August, 25, 2025 ZLDPF Chart by TradingView Zealand Pharma A/S Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$61.00$61.00$61.00$61.0020 shs$4.33 billion08/20/2025$61.00$61.00$61.00$61.00159 shs$4.33 billion08/19/2025$61.00$61.00$61.77$61.001,804 shs$4.33 billion08/18/2025$57.50$61.00+6.09%$61.77$61.001,804 shs$4.33 billion08/15/2025$55.02$57.50+4.52%$57.50$57.04758 shs$4.08 billion08/14/2025$53.50$55.02+2.83%$55.27$53.405,390 shs$3.91 billion08/13/2025$53.50$53.50$53.50$53.50126 shs$3.80 billion08/12/2025$50.14$53.50+6.70%$53.50$53.50126 shs$3.80 billion08/11/2025$50.14$50.14$50.14$50.143 shs$3.56 billion08/08/2025$50.14$50.14$50.14$50.14150 shs$3.56 billion Get the Latest News and Ratings for ZLDPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Zealand Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$50.20$50.14-0.12%$50.14$50.14150 shs$3.56 billion08/06/2025$50.20$50.20$50.25$49.98410 shs$3.57 billion08/05/2025$52.77$50.20-4.87%$50.25$49.98410 shs$3.57 billion08/04/2025$52.77$52.77$52.77$52.777 shs$3.75 billion08/01/2025$52.77$52.77$52.77$52.77196 shs$3.75 billion07/31/2025$54.60$52.77-3.35%$52.77$52.77196 shs$3.75 billion07/30/2025$54.60$54.60$54.60$54.11450 shs$3.88 billion07/29/2025$61.06$54.60-10.57%$54.60$54.11450 shs$3.88 billion07/28/2025$61.06$61.06$61.06$61.063 shs$4.34 billion07/25/2025$61.06$61.06$61.06$61.06153 shs$4.34 billion07/24/2025$58.40$61.06+4.55%$61.06$61.06153 shs$4.34 billion Related Companies GNMSF Stock Chart GMAB Stock Chart VTRS Stock Chart ASND Stock Chart RDY Stock Chart QGEN Stock Chart MRNA Stock Chart BBIO Stock Chart VRNA Stock Chart ELAN Stock Chart Receive ZLDPF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Zealand Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:ZLDPF) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zealand Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Zealand Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access